Business
NeuroOne®#¹⁶⁰;to Participate in the 35th Annual Roth Conference
EDEN PRAIRIE, Minn., March 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical
About this update from Neuroone Medical Technologies Corporation
[{"type":"text","content":"EDEN PRAIRIE, Minn., March 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (\"NeuroOne\" or the \"Company\"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the 35th Annual Roth Conference being held March 12-14, 2023 in Dana Point, California. Dave Rosa, CEO of NeuroOne, will host one-on-one meetings with institutional investors and analysts on Monday, March 13th and Tuesday, March 14th.\n\n \n \n \n \n \n \n\n \nConference Details: \nLocation:\nThe Ritz Carlton, Laguna Niguel in Dana Point, California.\nRegistration:\nAvailable on the conference website.\n1x1 meetings:\nInvestors may request a meeting by contacting a Roth representative at 800.678.9147 or by contacting NeuroOne investor relations.\nAbout NeuroOne\nNeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com. \nForward Looking Statements\nThis press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Except for statements of historical fact, any information contained in this presentation may be a forward–looking statement that reflects NeuroOne's current views about future events and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. In some cases, you can identify forward–looking statements by the words or phrases \"may,\" \"might,\" \"will,\" \"could,\" \"would,\" \"should,\" \"expect,\" \"i...